FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075813 [Registered on: 24/10/2024] Trial Registered Prospectively
Last Modified On: 22/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative clinical study of Aragwadha churna and Guduchi churna in Vatarakta  
Scientific Title of Study   Effect of Aragwadha churna as compared to Guduchi churna in management of Vatarakta (Gout):A Randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  VDSonam Gajendra Dhiwar  
Designation  PG Scholar 
Affiliation  Shri Ayurved Mahavidyalaya, Nagpur  
Address  Kayachikitsa Department,Pakwasa Samnavaya Rugnalaya,Shri Ayurved Mahavidyalaya,Hanuman Nagar,Nagpur

Nagpur
MAHARASHTRA
440024
India 
Phone  9637639806  
Fax    
Email  dhiwarsonam97@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Mrityunjay Sharma 
Designation  Asso.Professor 
Affiliation  Shri Ayurved Mahavidyalaya,Nagpur  
Address  Kayachikitsa Department, Pakwasa Samnavaya Rugnalaya, Shri Ayurved Mahavidyalaya, Nagpur

Nagpur
MAHARASHTRA
440024
India 
Phone  9373103182  
Fax    
Email  mrityunjaysharma22@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vd Mrityunjay Sharma 
Designation  Asso.Professor 
Affiliation  Shri Ayurved Mahavidyalaya,Nagpur  
Address  Kayachikitsa Department, Pakwasa Samnavaya Rugnalaya, Shri Ayurved Mahavidyalaya Nagpur

Nagpur
MAHARASHTRA
440024
India 
Phone  9373103182  
Fax    
Email  mrityunjaysharma22@gmail.com  
 
Source of Monetary or Material Support  
Shri Ayurved Mahavidyalaya, Nagpur  
 
Primary Sponsor  
Name  VdSonam Gajendra Dhiwar  
Address  Kayachikitsa Department, Pakwasa Samnavaya Rugnalaya,Shri Ayurved Mahavidyalaya,Nagpur  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
VdSonam Gajendra Dhiwar   Shri Ayurved Mahavidyalaya, Nagpur   Kayachikitsa Department, Pakwasa Samnavaya Rugnalaya,Shri Ayurved Mahavidyalaya,Nagpur
Nagpur
MAHARASHTRA 
9637639806

dhiwarsonam97@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee of Shri Ayurved Mahavidyalaya, Nagpur   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M100||Idiopathic gout. Ayurveda Condition: VATARAKTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Aragwadha Churna, Reference: Charak samhita Kalpasthana, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 28 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Guduchi Churna , Reference: Charak samhita Chikitsasthana , Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 28 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient with sign and symptoms of Vatarakta as mentioned in Samhitas.
Patient age group between 30-60yrs.
Patients selected irrespective of age, Sex, socio economic status.
Patient with hyperuricemia 7-10 mg/dl.
Newly diagnosed patients. 
 
ExclusionCriteria 
Details  Pregnant women and lactating mothers.
Patients with sign and symptoms of Amavata and
Sandhigatavata.
Patient having sign and symptoms of vatarakta more than 1 year.(chronic gout).
Patient with uric acid level above 10 mg/ 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the effect of Aragwadha churna and Guduchi
churna in the management of vatarakta (gout)to be assessed
by relief of symptoms
To compare the effect of Aragwadha churna and Guduchi
churna in the management of vatrakta(gout) to be assessed
by sr.uric acid level 
Follow up will be taken every 7th day for 28 days 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the effect of Aragwadha churna and Guduchi
churna in the management of vatrakta(gout) to be assessed
by sr.uric acid level 
At the end of 28 days 
 
Target Sample Size   Total Sample Size="68"
Sample Size from India="68" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   05/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   In the present study, total 68 participants will be taken for trial dividing them in 2 equal groups.
Grp-A will receive the trial drug ’Aragwadha churna’ and Grp-B will receive the control drug
’Guduchi churna’ twice a day for 28 days. Follow up will be taken every 7th day for 28 days . Result will be concluded based on assessment criteria.
 
Close